|There is a lot of publicity surrounding a new cancer
treatment protocol that is presently undergoing clinical trials in
the USA, but has been used for years by hundreds of physicians
around the globe. It is called Poly-MVA.|
This is how it is
Poly-MVA is a new, nontoxic, powerful
antioxidant formula that protects both cellular DNA and RNA. The
scientifically designed mechanism of action is to “fix the cell” and
control the cancer, rather than “fight the cancer” and poison the
system. This method of
cancer treatment has clearly demonstrated safe, antitumoral
activity. Compared to chemotherapy, Poly-MVA offers an extremely
powerful alternative cancer treatment without the toxic side effects
associated with most Conventional Cancer Treatments.
is proving to be a viable alternative cancer treatment due to its
patented antiaging formula. Many of the signs we contribute to aging
can be slowed through the Poly-MVA cell protection. Doctors and
Patients worldwide are reporting the benefits of Poly-MVA.
Merrill Garnett, a doctor and research chemist,
of the Garnett McKeen Laboratory, in Stony Brook, New York is the
inventor and recipient of three U.S. patents for Poly-MVA. Dr.
Garnett discovered the world’s first nontoxic
“chemotherapy” agent which does no harm to the healthy
cells. Poly-MVA, however, is not so much a ‘drug’ as a ‘cell
nutrient’ or superfood supplement.
For nearly forty years, Dr.
Garnett has probed the secrets of molecular biology and the
mysteries of cells, following his revolutionary dream for a safe and
effective treatment for cancer. He saw cancer as the failure of
cells to regenerate normally in a default mode; instead cloning
itself within the cancer mechanism over and over again. He decided
this failure to mature was a problem of energetics in the cell's
Dr. Garnett began
the often lonely search to find a molecular compound that would
restore healthy pathways for growth and normal development within
the cell—pathways missing in the cancer cells. He searched for a
metallo-organic compound that would act as a molecular shunt to
restore the cell’s healthy
and some 20,000 compounds later, he discovered that palladium
combined with lipoic acid, B-12 and thiamine created an extremely
useful and safe cellular nutrient. Subsequent tests have proved that
Poly-MVA is a safe and effective antitumoral
In 1995 Dr. Garnett patented a non-toxic
chemotherapeutic agent targeting only the malignant cells which
agent, at the same time, is related to specific changes in energy
metabolism. This compound was named POLYDOX (U.S. trials) or
Poly-MVA (Canada and Mexico), or LAPd by some researchers. The MVA
stands for minerals, vitamins, and amino acids, and LAPd is Lipoic
Acid/palladium complex. When lipoic acid, a powerful antioxidant
with many biological functions, is connected to an electrically
charged metallic substrate, and joined with various B vitamins, the
resulting complex becomes totally soluble in water and fat. It can
easily and safely travel throughout the body and into every cell,
crossing the blood/brain barrier as well. Therefore, performing that
journey across the blood/brain barrier - impossible for most drugs,
including chemotherapy - makes Poly-MVA excellent in cases where no
other remedies are possible. Poly-MVA has shown to be beneficial in
cases of breast, prostate, colon, lung, stomach and brain cancer,
and has also been used successfully in cases of psoriasis - a
disease which often develops into cancer.
"You haven't seen Poly-MVA on the six o'clock news or Sixty
Minutes yet, because patient trials are still being conducted in
this country. But I'm already recommending Poly-MVA to every new
cancer patient. Why am I so confident about Poly-MVA? First, this
natural remedy is already being used in Europe, Australia, South
America and India. Plus, Poly-MVA is a natural substance (a
combination of Alpha Lipoic Acid and the element Palladium) and has
absolutely no side effects, unlike radiation, chemotherapy or
Writes Dr. Stephen Sinatra
Simply said, Poly-MVA seeks out and destroys
any cancer cells in your body by stealing their electromagnetic
energy. In other words, it pulls the cancer cells' batteries out,
and the dead cancer cells are flushed out of your body. At the same
time, Poly-MVA invigorates your normal cells, helping repair any
damage the cancer may have done."
, a non-profit organization, reports on the
following early clinical cases:
The first report of clinical studies of PolyMVA was presented
by the late Rudolf E. Falk, an oncological surgeon at the University
of Toronto, in March 1994. Dr. Falk reported that the compound was
administered intravenously, subcutaneously (under the skin) and per
Os in a modified phase 2 study. To quote from Dr. Falk's summary,
"95 patients were treated; these included breast, lung, colorectal,
prostate, pancreatic, ovarian, malignant melanoma and primary brain
neoplasia. 90% of the patients were in the category of having failed
all available therapy. 88 are surviving on therapy with a mean
survival time of 9 months. The anticipated survival time of this
group, from available statistics would vary from 20% to 60% at 6
months. All of these patients received moderate doses of
The first 27 patients given PolyMVA were
all considered terminal, and all refused to continue with chemotherapy. They
were placed on a "health promotion program" as outlined in The Definitive Guide to
Cancer, Chapter 23. The cancers involved brain, tongue,
esophagus, lung, breast, stomach, colon, pancreas, prostate, lymph,
blood, and marrow. All had metastasis. All were given 5 drops four
times daily as a loading dose. 13 reported improvements in either
appetite, weight gain, increased energy or reduction in pain within
the first 7 days of starting PolyMVA. At the end of 14 days 6
additional patients reported improvement. None of the 27 patients
reported adverse reactions.
We learned from this small study (1) that
the initiating dose was inadequate, (2) rapid improvements can be
expected in over 60% of patients with a variety of malignant
conditions, and (3) PolyMVA is non-toxic. With this low dose, some
patients demonstrated clinical changes indicating early improvement.
A few anecdotal reports follow:
75 year old female with glioblastoma
presented with history of debulking surgeries and 2 rounds of
radiation. As a last resort her cancer center neurologist placed her
on massive, experimental doses of tomoxifen. She entered the
hospital in Baja California requiring support on both arms to walk
up the short ramp. Her memory was impaired, she had slurred speech.
Convulsions were under control with dilantin. On the 3rd day after
beginning PolyMVA her memory had improved as had her slurred speech.
She walked out of the hospital unaided to continue therapy at home.
She lived 6 months. Her immediate death is attributable to the side
effects of the tamoxifen which she continued to take before and
after the PolyMVA.
Glioblastoma patients usually have a
dramatic, early response similar to Mr. D. age 66. His tumor
inactivated his right leg and foot and caused generalized
convulsions which were poorly controlled by tegretol, or dilantin. I
received a phone call from Mr. D. four days after he began PolyMVA.
He said his paralysis was gone and he could walk outside and water
the lawn and ride his stationary bicycle. Eight days after beginning
he called again to report that his convulsions were now localized
and almost gone.
Pain from metastatic breast cancer to the
spine and right hip in CF age 56 required a right hip replacement
which gave relief from hip pain, but did not effect the spine. She
started PolyMVA and within 2 weeks her "back pain stopped" and she
returned to her legal research employment. Most breast cancer
patients report at least temporary improvement.
Two cases of cancer of esophagus
requiring MS for pain relief, cachectic and terminal when they
started PolyMVA. Mr. G. age 62 was in a Mexican hospital when he was
scheduled to began the PolyMVA. LS age 45 took the PolyMVA for home
use. Mr. G died within 6 weeks, but an investigation uncovered the
fact hat he was never given the PolyMVA. He was given Laetril alone.
LS reported increased strength and weight gain and is still living
(2 years from starting PolyMVA).
Diagnosed in April 1995 a female multiple
myeloma patient from Alaska with two degrees, a Ph.D. and J.D. sent
us a letter dated March 1997 that after taking PolyMVA her blood
tests and examinations showed " no measurable signs of multiple
myeloma carcinoma" and her doctors said "She is in total
Colon cancer patients with obstruction
reported improvement using the PolyMVA by enema. This is logical
since PolyMVA is soluable in fat and liquid.
Clinical studies by Dr.
Dr. James Forsythe has been conducting a Poly-MVA outcome
based investigation on various Stage IV Cancers since January of
2004 in Reno, Nevada and has seen encouraging results. "We have seen
patients go into full remission with aggressive, stage IV cancers
and we see continued positive responses in others with previously
chemo-resistant cancer. Other benefits from Poly-MVA are a
significantly improved quality of life and a substantial reduction
in the number and severity of side effects from chemo and radiation
To date, 207 patients are involved in the
investigation. The patients are classified into two groups. The
first group is administered both the Poly-MVA and chemotherapy. The
other group, who refused chemotherapy were on the supplement only.
In both groups, the Poly-MVA dosage is administered intravenously
for a fifteen day period. The patient is then switched to an oral
dosage which could take it up to six to eight months. After six
months a maintenance dosage is administered depending upon the
remission of the tumor. Because this is an ongoing clinical study,
there is no charge for the supplement, but there is a small
The Poly-MVA clinical results: a 70
percent response rate which included partial remission and complete
remission responses in the group that received both the chemotherapy
and Poly-MVA supplement and a 42 percent response rate from the
group who received the supplement exclusively. (Partial reduction
means a 50 percent reduction in the size of the tumor mass and
complete reduction means a disappearance of the disease resulting
from a physical examination, scanning and tumor markers.)
information on animal and human studies, go to
Poly-MVA: Research and Clinical
Experience in Individuals with Strokes, Cancer and Anti-Aging
M.D., D.Ht., D.A.B.F.M.
prostate health: Shari Lieberman PhD, CNS, FACN discusses
cancer case studies with the Foundation for Advancement in
Cancer Research (Sept.2006)|
FACR: What can be done nutritionally to
support conventional prostate cancer treatments?
Dr. Lieberman: Poly-MVA is an excellent
choice both for those who choose the "watchful waiting" approach and
those that want nutritional support as an adjuvant to standard
FACR: Poly-MVA is said to have a
particularly interesting mechanism of action. Can you describe
Dr. Lieberman: It actually has a
two-step process for its mechanisms of action. Poly-MVA is comprised
of an irreversibly bound trimer of lipoic acid, a powerful water and
fat-soluble antioxidant, and the mineral palladium with a thiamine
(B1) core. Consequently, it exists as a polymer rather than as a
single molecule. That means Poly-MVA can accept and donate energy
(electron charge) at a much greater magnitude then a single molecule
like other nutrients. This enables Poly-MVA to shuttle energy to the
mitochondria while, at the same time, protecting DNA and other
cellular tissue from oxidative stress or free radical damage that
occurs during normal cellular metabolism and, especially, during
times of disease (like cancer) or during the course of treatments
(like radiation and chemotherapy). Essentially, Poly-MVA converts
free radicals into usable cellular energy, benefiting and nourishing
FACR: Does this mean that Poly-MVA can
provide the same energy to cancer cells?
Dr. Lieberman: No. Studies and much
research have demonstrated that cancer cells are unable to accept
the excess energy Poly-MVA provides. This is because malignant cells
function in a hypoxic (low oxygen) environment, typically using
sugar to generate the energy needed to survive. The production of
oxygen radicals from the energy transfer generated in a hypoxic
environment facilitates cancer cell death by activating enzymes that
destroy the cells. Unlike cancer cells, healthy cells are richly
oxygenated. Consequently, Poly-MVA is non-toxic to the healthy
cells, which benefit from the energy boost and protective effect
triggered by the Lipoic Acid Palladium complex.
From the website of Dr. Forsythe (http://www.drforsythe.com/cw/poly.php):
Poly-MVA Stage IV Cancer
James W. Forsythe
“We have seen patients go into
full remission with aggressive, stage IV cancers and we see
continued positive responses in others with previously
chemo-resistant cancer. Other benefits from Poly-MVA are a
significantly improved quality of life and a substantial reduction
in the number and severity of side effects from chemo and radiation
therapies.” --Dr. James Forsythe
Dr. James W. Forsythe
M.D., H.M.D. has been conducting an outcome based Investigation on
various Stage IV Cancers since January of 2004 in Reno,
To date, 207 patients have
enlisted in the Investigation and thus far a 56 percent
overall positive response rate has been noted. Most
patients are using a full dosing (eight teaspoons per day) schedule.
For updated results on the Investigation, please click on the
following link Poly-MVA Investigation
For Dr. Forsythe, Poly-MVA
has now set a protocol for his combined approach because in his
experience using Poly-MVA with advanced cancer patients has been
Haro-Smith who is suffering from inoperable lung cancer and was told
she had only three to six months to live, has seen encouraging
results from the Poly-MVA."During the past five years I have been
treated by Dr. Forsythe with both low-dose fractionated chemotherapy
and alternative therapies. One year ago my cancer markers were
going up and Dr. Forsythe placed me on his clinical out-come based
protocol with Poly-MVA. Since then, this natural supplement
has stabilized my disease and normalized my markers."
Michael Oliver who has been battling prostate cancer tells
his story. "My PSA began to rise one year ago and Dr. Forsythe
placed me on his clinical investigation with oral Poly-MVA and since
this time my PSA has been near normal and I have not required any
chemotherapy. I have had no side-affects from the
Poly-MVA. I feel better and have more energy."
Currently, the Dr. Forsythe’s
Poly-MVA clinical investigation is completed. Dr. James
Forsythe's investigation was the largest and included treating all
types of cancer. Dr Forsythe is as an Associate Professor of
Alternative Medicine at the University of Nevada,
To see if Poly-MVA is
right for you or your loved one, please give us a call. For more
information or questions on Poly-MVA, please call our office during
regular business hours at 775-827-0707
The top three cancers that were highly
responsive to the Poly-MVA treatment were prostate, breast and
non-small cell lung cancer. Surprisingly non-small cell lunge
cancer is, in general, not a high responder to conventional
treatments. Colorectal cancers were the least responsive.
Poly-MVA appears to be a safe and
effective natural food supplement for palliative assistance in Stage
IV cancer patients either with or without concomitant
The safety profile is excellent and
there was no treatment-related deaths or any significant adverse
reactions or negative interactions with chemotherapy or hormonal
An IV loading dose of Poly-MVA confers a
12 percent improved overall response rate in this investigation.
Dr. James Forsythe's
"Poly-MVA Outcome Based" investigation included treating all types
of cancer. Dr Forsythe is as an Associate Professor of Alternative
Medicine at the University of Nevada, Reno.
This investigation has been presented
to the Nevada State Board of Homeopathic Medicine. This
investigation has not received FDA approval; however, an IRB is
pending in the State of Nevada.
From the Townsend Letter for Doctors
& Patients: a long and extremely informative article about Poly
MVA, including clinical cases, written by Dr. Morton
How does Poly-MVA
For an illustrated explanation, click
For a list of
practitioners, click here. (Please note: Some of the addresses in these lists may not be
on Foundation for Advancement in
Post Date : Friday July 21 2006
New York City "A new proprietary
product called Poly-MVA has shown highly promising preliminary
results in stabilizing prostate cancer without producing any of the
dreaded side effects commonly associated with conventional
treatments, according to a just-published report.
the report, Dr. Shari Lieberman, Ph.D., C.N.S., F.A.C.N. and Dr.
James W. Forsythe, Certified Board Oncologist, M.D., H.M.D.,
thoroughly documented the case studies of three men "ages 59, 73 and
77" who were diagnosed at various stages of prostate cancer and
adamantly refused any conventional treatment.
these men refused conventional treatment is because they were so
worried about the potential side effects, including impotence,
incontinence and loss of sexual desire" Dr. Lieberman says. "They
just said no".
The patients were given Poly-MVA while being
closely monitored by an oncologist. All three showed dramatic
improvement, with significantly lowered PSA levels and scores of 100
percent on a performance scale. They also experienced significant
improvement with such associated symptoms as nocturia (excessive
urination at night) dysuria (painful or difficult urination), and
hematuria (blood in the urine). Two of the men remain sexually
active; the third was inactive before treatment started.
patients are happy and very satisfied with the outcome," Dr.
Lieberman says. "They feel great and continue to take Poly-MVA while
being monitored by their oncologist."
Used as a dietary
supplement, Poly-MVA (which stands for POLY-Palladium Lipoic Complex
and MVA- minerals, vitamins and amino acids) contains a proprietary
formulation of palladium, alpha-lipoic acid, molybdenum, rhodium,
ruthenium, thiamine, riboflavin, cyanocobalamin, formyl-methionine,
and N-acetylcysteine. The primary active ingredient, a lipoic
acid/palladium complex, or "LAPd" for short, has undergone extensive
testing and is considered extremely safe with 15 years of human use.
Preliminary research on LAP suggests that it may also
improve outcomes in a patient receiving radiation and chemotherapy
by helping to protect normal, healthy cells while the patient is
receiving treatments. Additionally, Poly-MVA may provide healthy
cells with a boost in energy, which could explain why all three men
scored so high on the performance scale.
With a new case of
prostate cancer diagnosed every 2.6 minutes, the authors say the
obvious benefit of these three case studies is that other patients
who refuse conventional treatment may also benefit by taking
Poly-MVA while being closely monitored by an
"While these cases are moderate in duration (7-12
months) they provide compelling evidence that this formulation may
be worthwhile for men who refuse any conventional treatment," the
The complete study is published in Alternative
& Complementary Therapies, August 2005 and is available at the
publisher's website at www.liebertonline.com.
Lieberman, Ph.D, C.N.S., F.A.C.N., is a research scientist and
industry consultant based in New York City and Pompano Beach,
Florida. She is also the Founding Dean of New York Chiropractic
Collegeâ€™s (Seneca Falls, NY) MS Degree Program in Clinical
James W. Forsyth, M.D., H.M.D., is the medical
director of the Century Wellness Clinic, Reno, Nevada, and an
associate professor of medicine and pathology at the University of
Nevada Medical School, also in Reno.
Abstracts on clinical trials
, research involving Poly-MVA click here.
From http://www.drlam.com/private/poly_mva.cfm ,
Guidelines for the Use of Poly-MVA
safe, even for pregnant women, nursing mothers, and children under
the age of two. Extensive testing, both in the laboratory and in the
field over the last ten years, has proven this. There is no known
level of Poly-MVA above which toxicity will occur. Poly-MVA does not
harm normal cells -- even rapidly-dividing ones. Poly-MVA hydrates
and energizes normal cells, while either normalizing or killing
Books about Poly-MVA on Amazon:
Sources (where to
Google, under the search term, poly-mva, you will find many more
What does Poly-MVA mean for the
It is a liquid supplement, taken
The good news is, it is backed by good research data.
Reputable physicians are using it with good result. It is not a
drug, but a dietary supplement, so it is safe, non-toxic, no side
effects. It can be taken orally, although the doctors who use it
prefer to start intravenously, and only later do they switch to oral
intake. According to posted literature, it is safe even for children
under 2 years, for pregnant women and for nursing mothers;
however, check this out with a licenced health care
The fact that it crosses the blood/brain
barrier gives hope to brain tumor patients. It is also recommended
for leukemia. This is, without doubt, an important new tool in the
hands of integrative doctors.
The other side of the coin is
that it is expensive. It is not a magic bullet, not a panacea, yet
for many, if not most cancer patients, Poly-MVA would consume most
of their budget. If it works, that's great, but if it doesn't, there
is no money left to switch to other treatments.
monotherapies almost never succeed. A whole combination of remedies
are needed, and some of the components in the combination may have
to be changed to something else. The patient cannot afford to gamble
on one drug or supplement, no matter how enthusiastically it is
I am not saying that the promotion is misleading.
However, if you carefully examine it, it tells you that the
treatment is far from perfect. It is a powerful product, but other
products are also needed to ensure the desired outcome. So, what am
I really saying?
In my opinion, it is a matter of budgeting.
If the price of Poly-MVA doesn't exhaust most of your funds, Poly
may be an excellent choice. However, if it eats up most of your
funds, think carefully. There are other, much cheaper treatments
available, and some of them may even be better than
Keep your options open.
|© Gabe Bartha
2007. All rights reserved|